Cue Biopharma, Inc. (CUE)
NASDAQ
Cue Biopharma, Inc. Operating Income 2018–2025
Cue Biopharma, Inc. annual/quarterly operating income history and growth rate from 2018 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cue Biopharma, Inc. operating income for the quarter ending March 31, 2026 was -5.4 M, a 56.48% decrease year-over-year.
- Cue Biopharma, Inc. operating income for the twelve months ending March 31, 2026 was -33.9 M, a 21.72% decrease year-over-year.
- Cue Biopharma, Inc. annual operating income for 2025 was -26.6 M, a 36.02% decrease from 2024.
- Cue Biopharma, Inc. annual operating income for 2024 was -41.5 M, a 20.42% decrease from 2023.
- Cue Biopharma, Inc. annual operating income for 2023 was -52.1 M, a 2.02% decrease from 2022.
- Cue Biopharma, Inc. annual operating income for 2022 was -53.2 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cue Biopharma, Inc. Operating Income — FAQ
Cue Biopharma, Inc. (CUE) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Cue Biopharma, Inc.'s operating income?
Cue Biopharma, Inc. (CUE) reported operating income of -$27M for fiscal 2025.
Where can I see CUE's operating income history?
The chart and table above show Cue Biopharma, Inc.'s operating income by year and by quarter, including the growth rate.